Institut Paoli Calmettes Chronic Lymphatic Leukemia Database
Recruiting
- Conditions
- Leukemia, Lymphocytic, Chronic, B-Cell
- Registration Number
- NCT02869529
- Lead Sponsor
- Institut Paoli-Calmettes
- Brief Summary
- Database of Institut Paoli-Calmettes patients diagnosed with chronic lymphatic leukemia 
- Detailed Description
- Not available 
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 4200
Inclusion Criteria
- Diagnosis of chronic lymphatic leukemia
Exclusion Criteria
- Score of Matutes <4
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
- Name - Time - Method - Survival of patients - 10 years - Overall survival of all patients who come in the center 
- Secondary Outcome Measures
- Name - Time - Method - Collection of patients characteristics - 10 years - Collection of characteristics of patients treated at Institut Paoli Calmettes in order to set up prospective and retrospective studies 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms in BCR signaling are being studied in NCT02869529 for B-cell chronic lymphatic leukemia?
How does the observational data from NCT02869529 compare outcomes of chemoimmunotherapy vs. BTK inhibitors in B-cell CLL patients?
Which biomarkers in NCT02869529 correlate with progression-free survival in B-cell CLL patients with IGHV mutations?
What adverse events are reported in NCT02869529 for BTK inhibitor-treated B-cell CLL patients and how are they managed?
What combination therapies in NCT02869529 show improved efficacy in B-cell CLL compared to monotherapy with venetoclax or ibrutinib?
Trial Locations
- Locations (1)
- Institut Paoli-Calmettes 🇫🇷- Marseille, Bouches-du Rhône, France Institut Paoli-Calmettes🇫🇷Marseille, Bouches-du Rhône, FranceDominique GENRE, MDContact+33 4 91 22 37 78drci.up@ipc.unicancer.fr
